Transcending Numerology Red flags, Aakash Healthcare hugely excelled in 2024

New Delhi:  Numbers were not so right for 2024 as numerology foretold and calamitous events one after another unto last amply proved. But Aakash Healthcare bucked the trend and hugely excelled to the pleasant surprise of hospital group’s Guinness book fame numerologist patriarch J C Chaudhry. Yesteryear proved hugely transformative in Infrastructure Development and patient care. It became evidently clear that for the leader Managing Director Dr Aashish Chaudhry world is his oyster and he will continue pushing the envelope further towards excellence.

Contrary to numerology apprehensions, the leadership of his son and MD of Aakash Healthcare, Dr Aashish Chaudhry showed a rare brilliance..Dr Chaudhary put his best foot forward in terms of Infrastructure development and patient care which proved quite transformative. Incidentally, Dr Chaudhry, a well known orthopaedic and knee replacement surgeon walked along oft repeated phrase ‘like father like son’ also earning Guinness Book fame for largest digital knee joint care session in the world this year.

In a media interaction on January 8 in Le Meridian, Dr Aashish Chaudhry beamed with confidence and gave impression that world is his oyster and he is ready to push the envelope still further to make Aakash Healthcare one of the best healthcare model in India. Dr chaudhry gave a detailed lowdown on his future expansion plans.

In 2024, Aakash Healthcare underwent huge infrastructural transformation which entailed addition of 100 beds, increasing the total bed capacity to 300, and opening of four new operation theaters making 12 ot in all. Add to it specialized units such as the Interventional Radiology Suite, Bronchoscopy Suite, and a Bone Marrow Transplant Unit.

“Healthcare is not just about treating diseases; it’s about transforming lives with compassion, innovation, and trust, said Dr.Aashish Chaudhry, Managing Director of Aakash Healthcare Super Speciality Hospital. He added,‘last year, we’ve reached new heights in surgical care, performing over 200 robotic surgeries, including groundbreaking procedures like robotic kidney transplants and complex cancer excisions. A highlight was the successful organ donation of 8 organs from a young brain-dead patient, showcasing our unwavering commitment to saving lives.”

Aakash Healthcare’s impact is not only national but global, having touched over 40 million lives and provided care to more than 50,000 international patients from over 55 countries. Dr. Aashish Chaudhary’s leadership has been instrumental in building trust and relationships with patients worldwide, which has been further reflected in the hospital’s excellent 4.7 Google rating, garnered from more than 22,000 reviews.

As part of Aakash Healthcare’s expansion, new specialties such as Paediatric Cardiology, Interventional Radiology, and Paediatric Nephrology were introduced, further enhancing the breadth of services available to patients.The healthcare provider is set to continue its growth trajectory with two major upcoming projects in 2025: the opening of a state-of-the-art Oncology Unit in Dwarka and a new specialized unit in Gurugram, Haryana.

Related Posts

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Gujarat based Senores Pharmaceuticals Ltd on Monday, December 15, announced that it has entered into a share purchase agreement to acquire a 100% equity stake in Apnar Pharma Private Ltd.…

Aytu BioPharma launches depression drug EXXUA in U.S. market

DENVER-  Aytu BioPharma, Inc. (NASDAQ:AYTU) announced Monday the commercial availability of EXXUA in the United States for the treatment of major depressive disorder (MDD). The small-cap biotech, with a market…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Aytu BioPharma launches depression drug EXXUA in U.S. market

Aytu BioPharma launches depression drug EXXUA in U.S. market

Delhi govt carries out 27 raids against fake medicine

Delhi govt carries out 27 raids against fake medicine

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

ITS in AMTZ, 70 Countries participated for Future of Health Technology

ITS in AMTZ, 70 Countries participated for Future of Health Technology

Glenmark Pharmaceuticals Ltd soars 0.2%, gains for fifth straight session

Glenmark Pharmaceuticals Ltd soars 0.2%, gains for fifth straight session